| Application no. and date | 08729939.2 (espacenet) (Federated) (European Patent Register), 20080215 | | Patent/reg. no. and date | DK/EP 2124547, 20180328 | | Publication date | 20091202 | | Priority no. and date | US 890236 P, 20070216, US 892552 P, 20070302, US 908205 P, 20070327, US 949347 P, 20070712, US 952289 P, 20070727, US 969192 P, 20070831, US 977216 P, 20071003 | | EP pub. no. and date |
EP 2124547 20091202 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | SH/GP/157141 | | Inventor | ERICKSON-MILLER, Connie, Lynn, 1250 South Collegeville Road
Collegeville, PA 19426, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A01N 33/16 (2006.01) , A61K 31/655 (2006.01) , A61K 45/06 (2006.01) , A61P 35/00 (2006.01) , A61P 35/02 (2006.01) | | Title | Fremgangsmåde til behandling af cancer | | Int. application no. | US2008054046 | | Int. publication no. | WO2008101141 | | Related patent (certificate) | | | Status | Ændret EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
